American Diversified Holdings Corporation News Releases

American Diversified Holdings Operating Division GlucoGuard Retains Global Contract Research Organization (CRO) to Begin Patient Studies as Required by the FDA

Wed, 01 Apr 2026 08:30:00 -0400

CRO to Incorporate DEXCOM's Continuous Glucose Monitoring "CGM" Technology In the GlucoGuard Multi Patient Study Del Mar, California--(Newsfile Corp. - April 1, 2026) - American Diversified Holdings Corporation (OTCID: ADHC) announce today that GlucoGuard has retained a internationally recognized Contract Research Organization (CRO) to begin its patient studies to establish safety and efficacy concerns as required by the FDA. The Scope of Work agreement will comply with the FDA's requests to...

American Diversified Holdings Corporation (ADHC) Announces Internal Technology Initiative Within Universal Wellness AI Division

Tue, 06 Jan 2026 09:00:00 -0500

Del Mar, California--(Newsfile Corp. - January 6, 2026) - American Diversified Holdings Corporation (OTCID: ADHC) ("ADHC" or the "Company"), a diversified holding company focused on emerging technologies and consumer wellness markets, today announced the launch of an internal technology initiative within its Universal Wellness AI division. The initiative is intended to support the Company's ongoing exploration of artificial intelligence, automation, and digital commerce tools within the wellness...

GlucoGuard a Division of American Diversified Holdings (ADHC) Successfully Submits Level 2 App Integration Through Dexcom's Developer Partner Program

Tue, 25 Nov 2025 09:00:00 -0500

Del Mar, California--(Newsfile Corp. - November 25, 2025) - American Diversified Holdings Corporation (OTCID: ADHC) announced today that GlucoGuard has completed the Level 2 App integration through DEXCOM's Developer Program. The project development is in conjunction with UC Irvine's MADO program through the California Institute for Telecommunications and Information Technology (CALIT2a).The Dexcom Developer Program is a partnership program that allows developers to access Dexcom API and...

GlucoGuard Receives $43 Million Enterprise Valuation From Prominent CFA Led Harbinger Research

Tue, 04 Nov 2025 09:00:00 -0500

ADHC Files July 31st, 2025 Annual Disclosure Del Mar, California--(Newsfile Corp. - November 4, 2025) - Harbinger Research, LLC an independent equity research firm with a focus on the small cap and microcap stocks, announced today that it has published a new research report on American Diversified Holdings Corporation/GlucoGuard (OTCID: ADHC).The report includes a valuation analysis, multi-year financial forecast model, and a value estimate of the Company and its shares. The report puts a fully...

American Diversified Holdings Corporation Receives $5,000,000 (Five Million) Financing Commitment from an Institutional Investment Fund

Thu, 16 Oct 2025 09:00:00 -0400

Del Mar, California--(Newsfile Corp. - October 16, 2025) - American Diversified Holdings Corporation (OTCID: ADHC) announced today that a prominent institutional investment fund has committed to providing up to $5,000,000 (Five Million Dollars) in financing to the company.The terms of the agreement provide for investment tranches to be delivered to ADHC based upon a ("Use Of Funds"). The proceeds of this investment are earmarked for the research and development of the GlucoGuard project and for...

GlucoGuard Receives Scope of Work (SOW) Proposal from Arete Bioscience for FDA Recommended Sleep Study

Tue, 14 Oct 2025 06:00:00 -0400

2 Prong Proposal Includes a 10 Patient, Physician Monitored Sleep Study to Observe Glucose Aspiration Risk and Record Effect of Blood Sugar Level Before and After Administration of Glucose Del Mar, California--(Newsfile Corp. - October 14, 2025) - American Diversified Holdings Corporation (OTCID: ADHC) announces today the GlucoGuard received a formal SCOPE OF WORK (SOW) from Arete Bioscience in response to the company's recent meeting with FDA officials. The FDA had indicated during this meeting...

ADHC Update on FDA Review of GlucoGuard's Breakthrough Device Application

Mon, 22 Sep 2025 09:00:00 -0400

Final Issues Have Been Clarified Identifying Basic Safety Concerns Del Mar, California--(Newsfile Corp. - September 22, 2025) - American Diversified Holdings Corporation (OTCID: ADHC) today the GlucoGuard development team has completed meetings with FDA officials pursuant to the company's Breakthrough Device Application.In attendance at the meeting were three senior FDA officials and the GlucoGuard development team. The GlucoGuard team was led by Dr. Steven Weber, MD, FACS (former FDA official...

ADHC Announces First Digital Asset Treasury Purchase With Acquisition of Solana Based OTCfi Tokens

Mon, 15 Sep 2025 09:00:00 -0400

Cryptocurrency Advisory Board "CCAB" Formed To Advise On Ongoing "DAT "Strategy Del Mar, California--(Newsfile Corp. - September 15, 2025) - American Diversified Holdings Corporation (OTCID: ADHC) today announced its first step in implementing its newly formed Digital Asset Treasury (DAT) Strategy with the acquisition of OTCfi tokens.This purchase makes ADHC one of the first publicly traded companies along with Metavesco, Inc. to add OTCfi to its balance sheet.ADHC additionally unveiled the...

Dr. Kunal Sur, PhD Co-Founder of Arete Bioscience Joins GlucoGuard's Scientific Advisory Board (SAB)

Mon, 04 Aug 2025 08:00:00 -0400

Dr. Sur's Commitment Aligns Arete Bioscience as GlucoGuard's Ongoing Engineering Partner Del Mar, California--(Newsfile Corp. - August 4, 2025) - The management team of GlucoGuard, a division of American Diversified Holdings (OTCID: ADHC) ("ADHC") announced today that Dr. Kunal Sur, PhD has agreed to join the company's Scientific Advisory Board. Dr. Kunal joins Dr. Stephen Weber, MD and GlucoGuards co-founder Zach Smith to guide GlucoGuard's next developmental phase. Dr. Sur is the co-founder...

American Diversified Holdings Corporation (ADHC) Provides Udpate on Arete Bioscience GlucoGuard Design Project

Mon, 14 Jul 2025 08:00:00 -0400

Del Mar, California--(Newsfile Corp. - July 14, 2025) - American Diversified Holdings Corporation (OTC Pink: ADHC) is pleased to announce the San Diego based bio engineering firm ARETE BIOSCIENCES, Inc. has made strong progress on several fronts. Arete Engineering team has reviewed all previous engineering schematics including patent filings and other intellectual property, incorporated The Food and Drug Administration's (FDA) recommendations into the design plans and created an indepth CAD plan...